Similarity Score |
Similarity Level |
Drug ID |
Developmental Stage |
0.9812 |
High Similarity |
NPD6797 |
Phase 2 |
0.9752 |
High Similarity |
NPD7251 |
Discontinued |
0.9571 |
High Similarity |
NPD4338 |
Clinical (unspecified phase) |
0.9571 |
High Similarity |
NPD7808 |
Phase 3 |
0.9565 |
High Similarity |
NPD7054 |
Approved |
0.9506 |
High Similarity |
NPD7472 |
Approved |
0.9387 |
High Similarity |
NPD7074 |
Phase 3 |
0.9264 |
High Similarity |
NPD3818 |
Discontinued |
0.9245 |
High Similarity |
NPD4381 |
Clinical (unspecified phase) |
0.9207 |
High Similarity |
NPD7804 |
Clinical (unspecified phase) |
0.9141 |
High Similarity |
NPD6168 |
Clinical (unspecified phase) |
0.9141 |
High Similarity |
NPD6166 |
Phase 2 |
0.9141 |
High Similarity |
NPD6167 |
Clinical (unspecified phase) |
0.9 |
High Similarity |
NPD3817 |
Phase 2 |
0.8994 |
High Similarity |
NPD1934 |
Approved |
0.8938 |
High Similarity |
NPD2393 |
Clinical (unspecified phase) |
0.8854 |
High Similarity |
NPD1512 |
Approved |
0.8827 |
High Similarity |
NPD3882 |
Suspended |
0.882 |
High Similarity |
NPD2801 |
Approved |
0.8726 |
High Similarity |
NPD1511 |
Approved |
0.8659 |
High Similarity |
NPD7075 |
Discontinued |
0.8634 |
High Similarity |
NPD4380 |
Phase 2 |
0.8598 |
High Similarity |
NPD4868 |
Clinical (unspecified phase) |
0.8537 |
High Similarity |
NPD5402 |
Approved |
0.8528 |
High Similarity |
NPD6801 |
Discontinued |
0.8488 |
Intermediate Similarity |
NPD6559 |
Discontinued |
0.8476 |
Intermediate Similarity |
NPD7096 |
Clinical (unspecified phase) |
0.8447 |
Intermediate Similarity |
NPD5403 |
Approved |
0.8438 |
Intermediate Similarity |
NPD4378 |
Clinical (unspecified phase) |
0.843 |
Intermediate Similarity |
NPD7993 |
Clinical (unspecified phase) |
0.8375 |
Intermediate Similarity |
NPD6799 |
Approved |
0.8323 |
Intermediate Similarity |
NPD5401 |
Approved |
0.8228 |
Intermediate Similarity |
NPD1550 |
Clinical (unspecified phase) |
0.8228 |
Intermediate Similarity |
NPD1552 |
Clinical (unspecified phase) |
0.8176 |
Intermediate Similarity |
NPD1549 |
Phase 2 |
0.8171 |
Intermediate Similarity |
NPD1653 |
Approved |
0.8167 |
Intermediate Similarity |
NPD7879 |
Clinical (unspecified phase) |
0.815 |
Intermediate Similarity |
NPD3751 |
Discontinued |
0.8129 |
Intermediate Similarity |
NPD3787 |
Discontinued |
0.8118 |
Intermediate Similarity |
NPD5494 |
Approved |
0.8095 |
Intermediate Similarity |
NPD8443 |
Clinical (unspecified phase) |
0.8072 |
Intermediate Similarity |
NPD6599 |
Discontinued |
0.805 |
Intermediate Similarity |
NPD2796 |
Approved |
0.8036 |
Intermediate Similarity |
NPD7819 |
Suspended |
0.8024 |
Intermediate Similarity |
NPD7411 |
Suspended |
0.8 |
Intermediate Similarity |
NPD5844 |
Phase 1 |
0.7988 |
Intermediate Similarity |
NPD7410 |
Clinical (unspecified phase) |
0.7987 |
Intermediate Similarity |
NPD1510 |
Phase 2 |
0.7977 |
Intermediate Similarity |
NPD7184 |
Clinical (unspecified phase) |
0.7966 |
Intermediate Similarity |
NPD7685 |
Pre-registration |
0.7965 |
Intermediate Similarity |
NPD6959 |
Discontinued |
0.7929 |
Intermediate Similarity |
NPD1465 |
Phase 2 |
0.7919 |
Intermediate Similarity |
NPD6232 |
Discontinued |
0.7892 |
Intermediate Similarity |
NPD6980 |
Clinical (unspecified phase) |
0.7886 |
Intermediate Similarity |
NPD7473 |
Discontinued |
0.7861 |
Intermediate Similarity |
NPD7199 |
Phase 2 |
0.7849 |
Intermediate Similarity |
NPD919 |
Approved |
0.7848 |
Intermediate Similarity |
NPD1612 |
Clinical (unspecified phase) |
0.7848 |
Intermediate Similarity |
NPD1613 |
Approved |
0.7841 |
Intermediate Similarity |
NPD7228 |
Approved |
0.7805 |
Intermediate Similarity |
NPD6190 |
Approved |
0.779 |
Intermediate Similarity |
NPD8055 |
Clinical (unspecified phase) |
0.7778 |
Intermediate Similarity |
NPD8312 |
Approved |
0.7778 |
Intermediate Similarity |
NPD8313 |
Approved |
0.7778 |
Intermediate Similarity |
NPD7266 |
Discontinued |
0.7766 |
Intermediate Similarity |
NPD6781 |
Approved |
0.7766 |
Intermediate Similarity |
NPD6779 |
Approved |
0.7766 |
Intermediate Similarity |
NPD6777 |
Approved |
0.7766 |
Intermediate Similarity |
NPD6782 |
Approved |
0.7766 |
Intermediate Similarity |
NPD6780 |
Approved |
0.7766 |
Intermediate Similarity |
NPD6776 |
Approved |
0.7766 |
Intermediate Similarity |
NPD6778 |
Approved |
0.7759 |
Intermediate Similarity |
NPD1247 |
Approved |
0.7746 |
Intermediate Similarity |
NPD6234 |
Discontinued |
0.7744 |
Intermediate Similarity |
NPD1878 |
Clinical (unspecified phase) |
0.7737 |
Intermediate Similarity |
NPD7435 |
Discontinued |
0.7736 |
Intermediate Similarity |
NPD1240 |
Approved |
0.773 |
Intermediate Similarity |
NPD970 |
Clinical (unspecified phase) |
0.7727 |
Intermediate Similarity |
NPD7852 |
Clinical (unspecified phase) |
0.7708 |
Intermediate Similarity |
NPD7584 |
Approved |
0.767 |
Intermediate Similarity |
NPD3926 |
Phase 2 |
0.7663 |
Intermediate Similarity |
NPD8397 |
Clinical (unspecified phase) |
0.7661 |
Intermediate Similarity |
NPD37 |
Approved |
0.764 |
Intermediate Similarity |
NPD1607 |
Approved |
0.7636 |
Intermediate Similarity |
NPD3750 |
Approved |
0.763 |
Intermediate Similarity |
NPD4965 |
Approved |
0.763 |
Intermediate Similarity |
NPD4967 |
Phase 2 |
0.763 |
Intermediate Similarity |
NPD4966 |
Approved |
0.7625 |
Intermediate Similarity |
NPD943 |
Approved |
0.7606 |
Intermediate Similarity |
NPD8090 |
Clinical (unspecified phase) |
0.7605 |
Intermediate Similarity |
NPD6143 |
Clinical (unspecified phase) |
0.7595 |
Intermediate Similarity |
NPD1529 |
Clinical (unspecified phase) |
0.7578 |
Intermediate Similarity |
NPD230 |
Phase 1 |
0.7578 |
Intermediate Similarity |
NPD1933 |
Approved |
0.7552 |
Intermediate Similarity |
NPD7696 |
Phase 3 |
0.7552 |
Intermediate Similarity |
NPD7698 |
Approved |
0.7552 |
Intermediate Similarity |
NPD7697 |
Approved |
0.7547 |
Intermediate Similarity |
NPD3027 |
Phase 3 |
0.7538 |
Intermediate Similarity |
NPD8151 |
Discontinued |
0.7532 |
Intermediate Similarity |
NPD1530 |
Clinical (unspecified phase) |
0.753 |
Intermediate Similarity |
NPD4628 |
Phase 3 |
0.7529 |
Intermediate Similarity |
NPD7768 |
Phase 2 |
0.7514 |
Intermediate Similarity |
NPD8455 |
Phase 2 |
0.7513 |
Intermediate Similarity |
NPD7870 |
Phase 2 |
0.7513 |
Intermediate Similarity |
NPD7871 |
Phase 2 |
0.75 |
Intermediate Similarity |
NPD1551 |
Phase 2 |
0.75 |
Intermediate Similarity |
NPD6859 |
Clinical (unspecified phase) |
0.75 |
Intermediate Similarity |
NPD7875 |
Clinical (unspecified phase) |
0.75 |
Intermediate Similarity |
NPD6534 |
Approved |
0.75 |
Intermediate Similarity |
NPD7874 |
Approved |
0.75 |
Intermediate Similarity |
NPD6535 |
Approved |
0.7487 |
Intermediate Similarity |
NPD7701 |
Phase 2 |
0.7486 |
Intermediate Similarity |
NPD3749 |
Approved |
0.7439 |
Intermediate Similarity |
NPD651 |
Clinical (unspecified phase) |
0.7394 |
Intermediate Similarity |
NPD2935 |
Discontinued |
0.7382 |
Intermediate Similarity |
NPD7699 |
Phase 2 |
0.7382 |
Intermediate Similarity |
NPD7700 |
Phase 2 |
0.7377 |
Intermediate Similarity |
NPD7240 |
Approved |
0.7374 |
Intermediate Similarity |
NPD7801 |
Approved |
0.7374 |
Intermediate Similarity |
NPD7782 |
Clinical (unspecified phase) |
0.7374 |
Intermediate Similarity |
NPD7783 |
Phase 2 |
0.7365 |
Intermediate Similarity |
NPD7421 |
Clinical (unspecified phase) |
0.7362 |
Intermediate Similarity |
NPD447 |
Suspended |
0.7353 |
Intermediate Similarity |
NPD2533 |
Approved |
0.7353 |
Intermediate Similarity |
NPD2534 |
Approved |
0.7353 |
Intermediate Similarity |
NPD2532 |
Approved |
0.7333 |
Intermediate Similarity |
NPD7784 |
Clinical (unspecified phase) |
0.7333 |
Intermediate Similarity |
NPD8320 |
Phase 1 |
0.7333 |
Intermediate Similarity |
NPD3748 |
Approved |
0.7333 |
Intermediate Similarity |
NPD8319 |
Approved |
0.732 |
Intermediate Similarity |
NPD6823 |
Phase 2 |
0.731 |
Intermediate Similarity |
NPD7585 |
Approved |
0.7284 |
Intermediate Similarity |
NPD6798 |
Discontinued |
0.7273 |
Intermediate Similarity |
NPD8434 |
Phase 2 |
0.7273 |
Intermediate Similarity |
NPD8150 |
Discontinued |
0.7267 |
Intermediate Similarity |
NPD920 |
Approved |
0.7262 |
Intermediate Similarity |
NPD2800 |
Approved |
0.7261 |
Intermediate Similarity |
NPD1091 |
Approved |
0.7259 |
Intermediate Similarity |
NPD7583 |
Approved |
0.7251 |
Intermediate Similarity |
NPD7004 |
Clinical (unspecified phase) |
0.7243 |
Intermediate Similarity |
NPD4419 |
Clinical (unspecified phase) |
0.7239 |
Intermediate Similarity |
NPD6233 |
Phase 2 |
0.7229 |
Intermediate Similarity |
NPD7033 |
Discontinued |
0.7228 |
Intermediate Similarity |
NPD5953 |
Discontinued |
0.7225 |
Intermediate Similarity |
NPD4363 |
Phase 3 |
0.7225 |
Intermediate Similarity |
NPD4360 |
Phase 2 |
0.7216 |
Intermediate Similarity |
NPD7501 |
Clinical (unspecified phase) |
0.7186 |
Intermediate Similarity |
NPD6099 |
Approved |
0.7186 |
Intermediate Similarity |
NPD6100 |
Approved |
0.7184 |
Intermediate Similarity |
NPD7458 |
Discontinued |
0.7184 |
Intermediate Similarity |
NPD3226 |
Approved |
0.716 |
Intermediate Similarity |
NPD1243 |
Approved |
0.716 |
Intermediate Similarity |
NPD1652 |
Phase 2 |
0.716 |
Intermediate Similarity |
NPD4908 |
Phase 1 |
0.716 |
Intermediate Similarity |
NPD6674 |
Discontinued |
0.716 |
Intermediate Similarity |
NPD6832 |
Phase 2 |
0.7159 |
Intermediate Similarity |
NPD6844 |
Discontinued |
0.7152 |
Intermediate Similarity |
NPD6355 |
Discontinued |
0.7151 |
Intermediate Similarity |
NPD642 |
Clinical (unspecified phase) |
0.7143 |
Intermediate Similarity |
NPD2798 |
Approved |
0.7136 |
Intermediate Similarity |
NPD8155 |
Clinical (unspecified phase) |
0.7135 |
Intermediate Similarity |
NPD643 |
Clinical (unspecified phase) |
0.712 |
Intermediate Similarity |
NPD7286 |
Phase 2 |
0.7108 |
Intermediate Similarity |
NPD6651 |
Approved |
0.7099 |
Intermediate Similarity |
NPD9494 |
Approved |
0.7093 |
Intermediate Similarity |
NPD7390 |
Discontinued |
0.7083 |
Intermediate Similarity |
NPD6212 |
Phase 3 |
0.7083 |
Intermediate Similarity |
NPD6213 |
Phase 3 |
0.7083 |
Intermediate Similarity |
NPD6214 |
Clinical (unspecified phase) |
0.7081 |
Intermediate Similarity |
NPD1203 |
Approved |
0.7077 |
Intermediate Similarity |
NPD7237 |
Clinical (unspecified phase) |
0.7073 |
Intermediate Similarity |
NPD2313 |
Discontinued |
0.7073 |
Intermediate Similarity |
NPD4907 |
Clinical (unspecified phase) |
0.7067 |
Intermediate Similarity |
NPD5619 |
Clinical (unspecified phase) |
0.7063 |
Intermediate Similarity |
NPD4379 |
Clinical (unspecified phase) |
0.7048 |
Intermediate Similarity |
NPD5123 |
Clinical (unspecified phase) |
0.7048 |
Intermediate Similarity |
NPD5124 |
Phase 1 |
0.7048 |
Intermediate Similarity |
NPD1899 |
Clinical (unspecified phase) |
0.7044 |
Intermediate Similarity |
NPD1547 |
Clinical (unspecified phase) |
0.7041 |
Intermediate Similarity |
NPD2344 |
Approved |
0.7041 |
Intermediate Similarity |
NPD2346 |
Discontinued |
0.7024 |
Intermediate Similarity |
NPD2799 |
Discontinued |
0.702 |
Intermediate Similarity |
NPD7680 |
Approved |
0.7018 |
Intermediate Similarity |
NPD6398 |
Clinical (unspecified phase) |
0.7006 |
Intermediate Similarity |
NPD1548 |
Phase 1 |
0.6989 |
Remote Similarity |
NPD5808 |
Clinical (unspecified phase) |
0.6988 |
Remote Similarity |
NPD4060 |
Phase 1 |
0.6983 |
Remote Similarity |
NPD5353 |
Approved |
0.6973 |
Remote Similarity |
NPD2163 |
Approved |
0.697 |
Remote Similarity |
NPD3268 |
Approved |
0.6957 |
Remote Similarity |
NPD2403 |
Approved |
0.6954 |
Remote Similarity |
NPD7422 |
Clinical (unspecified phase) |
0.695 |
Remote Similarity |
NPD7211 |
Clinical (unspecified phase) |
0.694 |
Remote Similarity |
NPD5711 |
Approved |
0.694 |
Remote Similarity |
NPD5710 |
Approved |
0.6937 |
Remote Similarity |
NPD1610 |
Phase 2 |
0.6937 |
Remote Similarity |
NPD422 |
Phase 1 |
0.6928 |
Remote Similarity |
NPD4062 |
Phase 3 |
0.6927 |
Remote Similarity |
NPD7930 |
Approved |
0.6923
|
Remote Similarity |
NPD1509 |
Clinical (unspecified phase) |